BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10325197)

  • 1. Generating revenue through laboratory testing.
    Hannon F
    Hosp Entrep Newsl; 1987 Jun; 3(1):1-2, 8. PubMed ID: 10325197
    [No Abstract]   [Full Text] [Related]  

  • 2. The unordered test: cost of the benefit vs. benefit of the cost.
    Winkelman JW; Bernstein LH
    Pathologist; 1985 Jul; 39(7):12-6. PubMed ID: 10317618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Algorithms and protocols for DRG testing.
    Marchand A
    MLO Med Lab Obs; 1987 Apr; 19(4):30-5. PubMed ID: 10317885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surviving prospective reimbursement: how computers can help contain lab costs.
    Aller RD
    Pathologist; 1985 Apr; 39(4):12-6. PubMed ID: 10317589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitals can pull in extra 5% profit by marketing their slack lab capacity.
    Nathanson M
    Mod Healthc; 1983 May; 13(5):64, 67. PubMed ID: 10260321
    [No Abstract]   [Full Text] [Related]  

  • 6. Better quality medicine at lowered costs by a cost effective laboratory service system (CELSS).
    Nalbandian RM; Henry RL
    Mich Med; 1981 Aug; 80(23):428-9. PubMed ID: 6790915
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical audit. Putting pathology under the savings spotlight.
    Kerr C
    Health Soc Serv J; 1985 Dec; 95(4978):1576. PubMed ID: 10317686
    [No Abstract]   [Full Text] [Related]  

  • 8. Is that new instrument a winner?
    Stafford AC
    MLO Med Lab Obs; 1986 Apr; 18(4):24-8. PubMed ID: 10317714
    [No Abstract]   [Full Text] [Related]  

  • 9. The rising trend in outpatient testing.
    Hallam K
    MLO Med Lab Obs; 1986 May; 18(5):24-8. PubMed ID: 10317745
    [No Abstract]   [Full Text] [Related]  

  • 10. Speaking the language of financial management: a guide to analyzing costs.
    Valdiserri RO
    Pathologist; 1986 Nov; 40(11):31-3. PubMed ID: 10317825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision making in pathology: what is the impact of economic and technologic change?
    Davis GL
    Pathologist; 1985 Apr; 39(4):23-7. PubMed ID: 10317590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologists hope HHS clarification will give them leverage with hospitals.
    Wallace C
    Mod Healthc; 1984 Jun; 14(8):28, 30. PubMed ID: 10273518
    [No Abstract]   [Full Text] [Related]  

  • 13. Debugging a laboratory outreach program.
    Harris PC
    MLO Med Lab Obs; 1986 Nov; 18(11):65-72. PubMed ID: 10281020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dr. Derman testifies on MD-DRGs.
    Derman H
    Pathologist; 1986 Aug; 40(8):51-4. PubMed ID: 10311691
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital wins tax contest over pathology revenue: not unrelated business income.
    Schwartz R
    Health Law Vigil; 1980 Oct; 3(20):6-7. PubMed ID: 10324111
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of DRGs after year 3: Part II. How labs continue to cope.
    Hallam K
    MLO Med Lab Obs; 1986 Dec; 18(12):33-6. PubMed ID: 10311792
    [No Abstract]   [Full Text] [Related]  

  • 17. Directing the post-TEFRA laboratory.
    Sharp JW
    Pathologist; 1985 Feb; 39(2):15-8. PubMed ID: 10270443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal considerations in pathologists' contracting-recent developments.
    Polk LT
    Pathologist; 1981 May; 35(5):268-71. PubMed ID: 10251158
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments of the American College of Pathologists on proposed regulations on payment for physician services in institutional practice.
    Pathologist; 1982 Dec; 36(12):suppl ii-xii. PubMed ID: 10261169
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathologists to challenge Medicare rule.
    Lewis R
    Am Med News; 1983 Apr; 26(14):1, 19. PubMed ID: 10324806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.